Información del producto
- 1-Phenanthrenecarboxylic acid, dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester
- Abietic acid, dihydro-, methyl ester
- Dihydroabietic acid methyl ester
- Methyl (8Xi)-Abiet-13-En-18-Oate
- Methyl dihydroabietate
Methyl Dihydroabietate is a matrix metalloproteinase inhibitor that can be used for the treatment of osteoarthritis. It inhibits the activity of matrix metalloproteinases and, therefore, prevents the degradation of cartilage. Methyl Dihydroabietate has synergistic effects with levopimaric acid, a divalent hydrocarbon that inhibits the production of prostaglandins. This combination leads to increased viscosity and inhibition of cartilage degradation. Methyl Dihydroabietate also inhibits fatty acid oxidation products such as hydrogenated and nonpolar solvent compounds. These inhibitory effects on lipid oxidation may reduce inflammation in joints by decreasing free radicals and reactive oxygen species.
Propiedades químicas
Consulta técnica sobre: 3D-FBA96845 Methyl Dihydroabietate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.